rediff.com
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
Marksans Pharma Ltd. - Research Center
524404 MARKSANS Group (A) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Annual results in brief
(Rs crore)
Mar ' 17 Mar ' 16 Mar ' 15 Mar ' 14 Mar ' 13
Sales 215.84 366.82 408.68 318.26 196.47
Operating profit 24.18 112.58 118.83 87.13 48.44
Interest 3.44 6.20 13.11 15.21 10.13
Gross profit 27.58 106.38 105.72 71.92 38.31
EPS (Rs) 0.30 1.75 1.64 1.44 1.03
Annual  results in details
Mar ' 17 Mar ' 16 Mar ' 15 Mar ' 14 Mar ' 13
Other income 6.83 - - - -
Stock adjustment 0.67 4.17 1.36 -1.84 9.19
Raw material 100.88 156.72 193.56 142.63 65.96
Power and fuel - - - - -
Employee expenses 40.17 26.13 23.66 21.39 15.39
Excise - - - - -
Admin and selling expenses - - - - -
Research and development expenses - - - - -
Expenses capitalised - - - - -
Other expenses 49.93 67.22 71.28 68.95 57.48
Provisions made - - - - -
Depreciation 15.00 14.75 9.03 8.66 8.70
Taxation 0.35 20.14 29.58 7.70 -9.98
Net profit / loss 12.23 71.49 67.11 55.56 39.58
Extra ordinary item - - - - -
Prior year adjustments - - - - -
Equity capital 40.93 40.93 40.93 38.53 38.53
Equity dividend rate - - - - -
Agg.of non-prom. shares (Lacs) - - 2118.22 1878.15 1886.34
Agg.of non promotoholding (%) - - 51.75 48.75 48.96
OPM (%) 11.20 30.69 29.08 27.38 24.66
GPM (%) 12.39 - - - -
NPM (%) 5.49 - - - -
Close
Add Marksans Pharma Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Marksans Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close